cbdMD (YCBD) Short term Debt (2016 - 2024)

cbdMD's (YCBD) quarterly Short term Debt came in at $362021.0 in Q4 2024, down 69.09% quarter-over-quarter from $1.2 million in Q3 2024.

cbdMD (YCBD) Short term Debt (2016 - 2024) Analysis & Trends

cbdMD has disclosed Short term Debt across 4 years of filings, most recently posting $362021.0 for Q4 2024.

  • Short term Debt for Q4 2024 came in at $362021.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $362021.0 (changed N/A YoY), and the FY2024 annual result was $1.2 million, changed N/A from the prior year.
  • Short term Debt came in at $362021.0 for Q4 2024 at cbdMD, down from $1.2 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $1.2 million in Q3 2024 to a low of $362021.0 in Q4 2024.
  • The 3-year median for Short term Debt is $939826.0 (2020), against an average of $870911.6.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 cbdMD 3,884.57 -3.38 Mn 3.00 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 362,021.00
Sep 30, 2024 1.17 Mn
Mar 31, 2021 1.03 Mn
Dec 31, 2020 939,826.00
Sep 30, 2020 854,000.00
Sep 30, 2016 797,547.00